FindTrial
Sign In

A study of the range of clinical menifestations and future outcome of acute noncompressive myelopathy patients.

Study of clinical spectrum and outcome of acute noncompressive myelopathies.

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2011/091/000003
Enrollment
30
Registered
2011-02-03
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: NIL: NIL Control Intervention1: NIL: NIL

Sponsors

NIL
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: (1) Patients developing acute onset motor and/or sensory and/or sphincteric disturbance with/without a definite sensory level. (2) Neurological deficit maximal within 72 hours of symptom onset and no progression over 3 weeks. (3) Absence of mass lesion or structural abnormality on MRI.

Exclusion criteria

Exclusion criteria: (1)Presence of other known neurological diseases. (2)Clinical or radiological signs of involvement of brain matter. (3)H/O trauma to spinal cord. (4)H/O radiation to the spine in previous 10 years.

Design outcomes

Primary

MeasureTime frame
MODIFIED RANKIN SCALE AND MODIFIED BARTHEL ACTIVITY INDEXTimepoint: MONTHLY FOR 6 MONTHS—

Secondary

MeasureTime frame
contracture,pressure sore,bladder dysfunctionTimepoint: At admission and end of 6 months—

Countries

India

Contacts

Public ContactPROF R.K.GARG
garg50@yahoo.com05222258852

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026